Genovate Biotechnology (Taiwan) Insiders
| 4130 Stock | TWD 21.80 0.15 0.68% |
Genovate Biotechnology employs about 181 people. The company is managed by 2 executives with a total tenure of roughly 7 years, averaging almost 3.0 years of service per executive, having 90.5 employees per reported executive. Recap of Genovate Biotechnology's management performance can provide insight into the venture performance.
| Ming Peng Insider Deputy Operations |
| Zheng Chen Director General Manager, Director |
Genovate |
Genovate Biotechnology Management Team Effectiveness
Genovate Biotechnology's management efficiency ratios could be used to measure how well Genovate Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities.Genovate Biotechnology Workforce Comparison
Genovate Biotechnology Co is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 288. Genovate Biotechnology totals roughly 181 in number of employees claiming about 63% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.01 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01. Genovate Biotechnology Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Genovate Biotechnology Price Series Summation is a cross summation of Genovate Biotechnology price series and its benchmark/peer.
Genovate Biotechnology Notable Stakeholders
A Genovate Biotechnology stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Genovate Biotechnology often face trade-offs trying to please all of them. Genovate Biotechnology's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Genovate Biotechnology's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Zheng Chen | General Manager, Director | Profile | |
| Ming Peng | Deputy Operations | Profile |
About Genovate Biotechnology Management Performance
The success or failure of an entity such as Genovate Biotechnology often depends on how effective the management is. Genovate Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Genovate management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Genovate management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Genovate Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genovate Biotechnology Co. Check Genovate Biotechnology's Beneish M Score to see the likelihood of Genovate Biotechnology's management manipulating its earnings.
Genovate Biotechnology Workforce Analysis
Traditionally, organizations such as Genovate Biotechnology use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Genovate Biotechnology within its industry.Genovate Biotechnology Manpower Efficiency
Return on Genovate Biotechnology Manpower
| Revenue Per Employee | 2.4M | |
| Revenue Per Executive | 217.1M | |
| Net Income Per Employee | 2.1K | |
| Net Income Per Executive | 186K |
Additional Tools for Genovate Stock Analysis
When running Genovate Biotechnology's price analysis, check to measure Genovate Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovate Biotechnology is operating at the current time. Most of Genovate Biotechnology's value examination focuses on studying past and present price action to predict the probability of Genovate Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovate Biotechnology's price. Additionally, you may evaluate how the addition of Genovate Biotechnology to your portfolios can decrease your overall portfolio volatility.